The Weight of Empire: Eli Lilly and the Approaching Thaw

Numerous pharmaceutical houses, both established and nascent, have turned their gaze toward this burgeoning market, lured by the prospect of alleviating a widespread affliction and, of course, by the accumulation of considerable wealth. Few, however, possess the resources and resolve to mount a genuine challenge to Eli Lilly’s authority. Let us consider, then, those who might yet disturb the prevailing order.






